RENAL FUNCTION OUTCOMES IN DE NOVO KIDNEY TRANSPLANT RECEIVING TACROLIMUS WITH EVEROLIMUS AS A MAINTENANCE IMMUNOSUPPRESSION IN SENSITIZED PATIENTS WITH CPRA > 98% WITHOUT DONOR SPECIFIC ANTIBODIES (DSA)
TRANSPLANT INTERNATIONAL（2019）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined